US74276L1052
US74276L1052
PROCEPT BioRobotics Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.05B EUR | 1.29B EUR | 1.42B EUR | 1.77B EUR |
Enterprise Value | 874.78M EUR | 1.14B EUR | 1.26B EUR | 1.56B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -15.69x | -- | -- | -- |
Price to Sales | 3.12x | 3.83x | 4.42x | 7.42x |
Price to Book | 3.1x | 3.8x | 4.09x | 4.84x |
EV/Revenue | 2.59x | 3.39x | 3.9x | 6.55x |
EV/EBITDA | -7.95x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -4.65% | -6.57% | -5.66% | -2.23% |